Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-688
Closed -$1.52K 2149
2025
Q1
$1.52K Buy
688
+26
+4% +$95 ﹤0.01% 1974
2024
Q4
$2.74K Hold
662
﹤0.01% 1952
2024
Q3
$1.13K Sell
662
-659
-50% -$1.11K ﹤0.01% 1969
2024
Q2
$2.19K Buy
1,321
+910
+221% +$3.35K ﹤0.01% 1895
2024
Q1
$4.5K Buy
+411
New +$2.46K ﹤0.01% 1849
2023
Q4
Sell
-784
Closed -$2.42K 2147
2023
Q3
$2.42K Buy
+784
New +$3.59K ﹤0.01% 1954
2023
Q1
Sell
-2
Closed -$10 2214
2022
Q4
$10 Buy
+2
New +$25 ﹤0.01% 2143
2021
Q3
Sell
-32
Closed -$1K 2286
2021
Q2
$1K Buy
+32
New +$801 ﹤0.01% 2145
2014
Q3
Sell
-1,429
Closed -$4K 2039
2014
Q2
$4K Buy
+1,429
New +$3.81K ﹤0.01% 1864

Other funds holding NOTV

Federated Hermes's NOTV Position: Q2 2025 in Review

Federated Hermes sold out of Inotiv (NOTV) in Q2 2025, closing a stake of 688 shares — an estimated $1.52K sold.

Federated Hermes first reported a position in NOTV in Q2 2014 and held it in 9 quarters. The position peaked at $4.5K in Q1 2024. 74 funds tracked by Wall St. Rank hold NOTV as of Q2 2025.

  • Federated Hermes reported no remaining Inotiv position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 688 Inotiv shares in Q2 2025, an estimated $1.52K.
  • Federated Hermes first reported a position in Inotiv in Q2 2014 and held it in 9 quarters.
  • Federated Hermes's Inotiv position peaked at $4.5K in Q1 2024.
  • 74 funds tracked by Wall St. Rank held Inotiv as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.